Invest in the Medicines of Tomorrow

MorphoSys is a profitable growth company, building a strong therapeutic antibody pipeline with more than 90 projects originating from its proprietary technologies. MorphoSys participates in successful product development by its partners through milestones and future royalty payments for marketed drugs and increasingly also develops drugs on its own account for an even greater potential upside.

  • 03/03/2015 – 03/04/2015
    Credit Suisse Healthcare Conference
  • 04/16/2015
    8th Kempen Lifesciences Conference
  • 05/05/2015
    Publication of Three Months' Report 2015